Learn
Explore our list of resources
Depending on your rare disease journey, Global Genes provides you with the resource and community to enhance your learning.
Featured
Gene-Based Diagnosis 101: How to Successfully Navigate the Diagnostic Journey
As scientific innovation in genomic medicine continues to provide more hope for therapeutic options, there is a […]
Read moreA Case for Whole Genome Sequencing
The ability to diagnose rare genetic diseases through the use of genetic sequencing has improved to a […]
Read moreAdvances in Rare Immunological Diseases
Recent advances in rare immunological diseases have raised the exciting potential of cures for some disorders. Hear […]
Read moreDevelopmental Delays After Factor V Leiden Pregnancy
by Tiffany Burnette I was diagnosed with Factor V Leiden when I was pregnant with Sammy. While […]
Read morePatient Stories
Living and Advocating Through a Complex Medical Journey: Erythromelalgia, Visual Snow Syndrome, and Autoimmune Dysregulation
Hello, my name is Sierra Domb. Since childhood, I have experienced Erythromelalgia (EM) and Autoimmune Dysregulation (AD). […]
Read moreLiving with Brugada Syndrome
Brugada is insidious, especially for someone my age. It tends to “hide” in the ECG. Many times, it looks normal… but it isn’t. And with the myocarditis I had at the same time, it was even harder to get a correct diagnosis. The doctors didn’t know whether the findings were due to Brugada or to myocarditis. After my hospitalization, and after I suffered a fainting episode, it was finally decided that I should be implanted with a defibrillator (ICD). When it happened, I felt like life was given back to me.
Read moreHe Is Three. His Voice Isn’t Lost —It’s Waiting to Be Heard.
By the time a genetic diagnosis of a rare mutation in the PPP3CA gene finally arrived, critical months — even years — had slipped away. Milestones were missed while we waited for answers. Early concerns were minimized, and our pleas for help were too often brushed aside until delays became severe. That delay is not just a bureaucratic failure; it is lost opportunity — lost time for therapies that could have helped him build strength, communication, and independence.
Read moreThe Beginning of Our Lowe Syndrome Journey
By Caroline Tsai The sun blazes overhead without a cloud in sight. Only a high of 90 […]
Read moreInvincible Never Invisible: A Decade of InvisiYouth
I was competitive tennis player as a teen and was unfortunately injured in training, which resulted in dealing with an injury and neurovascular condition that changed the trajectory of my life. I was thrust into the world of living with a chronic illness, years of trying to find proper diagnoses and treatments, all while balancing life as a teen/young adult. During this entire young adult experience, my doctors would tell me “wait” till they could fix my health to live my life fully… I created InvisiYouth out of my love of philanthropy, and my newfound passion to giving a voice for the young adult population living with all chronic illnesses and disabilities for the non-medical aspects of their lives with health struggles.
Read moreBeauty in Being Rare
Classical HCU is a condition in which my liver has a defective enzyme that is supposed to break down methionine. Instead, it builds up and turns into homocysteine, which is extremely toxic to your body. These elevated levels can result in blood clots, strokes, and other life-threatening complications. I follow an extremely restrictive low-protein diet—only about 10 grams of whole protein per day—alongside a methionine-free formula, the medication called betaine, and a cocktail of vitamins and supplements.
Read moreLatest News
Savara’s Early Access Program
Savara’s Early Access Program (EAP) for molgramostim inhalation solution (molgramostim) in Autoimmune Pulmonary Alveolar Proteinosis (Autoimmune […]
Read morePublication Announcement — RARE-X: Advancing Rare Disease Research Through Patient-Driven Data
Global Genes is excited to announce “RARE-X: A patient-driven approach for collecting symptom and patient-reported outcome data […]
Read moreAccelerating Rare Disease Research Through Collaboration: Global Genes and Notre Dame Launch the Research Acceleration Program
Global Genes and University of Notre Dame have partnered to launch the Research Acceleration Program, a collaborative […]
Read moreRARE Advocacy Exchange Session 8, Knowing Your Rare Rights
This session recording is from Oct. 16, 2025 Rare Advocacy Exchange Session 8: Knowing the Rights for […]
Read moreGlobal Genes Guide to Starting a Nonprofit Patient Advocacy Organization
This Global Genes Quick Guide is a resource for advocates focused on pressing topics causing challenges in […]
Read moreRARE Advocacy Exchange Session 7, Getting a Precise Genetic Diagnosis
This session recording is from Sept. 18, 2025 Rare Advocacy Exchange Session 7: Getting A Precise Diagnosis […]
Read moreIndustry News
Targeting Iron Dysregulation in the Neurodegenerative Condition MSA
Multiple system atrophy is a rapidly progressive neurodegenerative condition that is often misdiagnosed as Parkinson’s disease but […]
Read moreBeren Raises $300 Million to Prepare for Potential Commercial Launch of NPC Therapy
Rare Daily Staff Beren Therapeutics said it raised $300 million to support the potential U.S. commercial launch […]
Read moreFDA Grants Gen1E Orphan and Rare Pediatric Disease Designations for DMD Therapy
Rare Daily Staff The U.S. Food and Drug Administration (FDA) has granted Gen1E Life Sciences both Orphan […]
Read moreFDA Grants RPDD to RedHill Biopharma for Neuroblastoma Therapy
Rare Daily Staff The U.S. Food and Drug Administration has granted RedHill Biopharma rare pediatric disease designation […]
Read moreIncyte to Acquire Vega for up to $2 Billion
Rare Daily Staff Incyte is expanding its hematology portfolio into bleeding disorders through a deal to acquire […]
Read moreSpruce Reports Positive Long-Term Data for MPS IIIB ERT
Rare Daily Staff Spruce Biosciences has reported long-term clinical data suggesting its experimental enzyme replacement therapy, tralesinidase […]
Read moreCartesian Deal Advances Development of In vivo CAR-T for Autoimmune Diseases
Rare Daily Staff Cartesian Therapeutics has entered a strategic licensing agreement with WestGene Biopharma aimed at accelerating […]
Read moreFDA Grants Breakthrough Therapy Designation to Biogen’s SMA Therapy
Rare Daily Staff The U.S. Food and Drug Administration has granted Breakthrough Therapy designation to Biogen’s experimental […]
Read moreZenas Reports Positive Results in IgG4‑RD Trial
Zenas Reports Positive Results in IgG4‑RD Trial to Date A drug designed to calm, rather than broadly […]
Read moreGenetic Counseling
Global Genes Guide to Genetic Diagnosis
This Global Genes Quick Guide is a resource for advocates focused on pressing topics causing challenges in […]
Read moreGlobal Genes 2025 Quick Guide Series
We are excited to announce the launch of a new series of Quick Guides for the […]
Read moreAngelina Spreading Light, Love, and Inspiration on CASK Gene Awareness Day
To recognize CASK Gene Awareness Day on July 15, Global Genes reached out to Giovi Moschoudis, mother […]
Read moreTeam Wally Inspires During Fragile X Awareness Month
To recognize Fragile X Awareness Month in July, Global Genes reached out to National Fragile X Foundation, […]
Read moreFrom First Symptoms to Advocate for Transverse Myelitis
To recognize Transverse Myelitis Awareness Month in June, Global Genes reached out to The MOG Project, a […]
Read moreMoving from Awareness to Action after Sickle Cell Disease Diagnosis
Karen L. Proudford, Ph.D. is the President of Williams E. Proudford Sickle Cell Fund, Inc., and daughter […]
Read moreResearch Readiness
Scientists Develop New Gene Editing Approach Capable of Gene-Sized Insertions
Rare Daily Staff Scientists at UMass Chan Medical School have unveiled a new gene editing approach that […]
Read moreTiny Worms May Unlock New Treatments for Rare Childhood Disorder
Rare Daily Staff Researchers at Brown University have developed genetically engineered versions of C. elegans—tiny worms commonly used […]
Read moreGene Therapy Innovators Share 2026 Breakthrough Prize
Rare Daily Staff The Breakthrough Prize Foundation awarded the 2026 Breakthrough Prizes in Life Sciences to a […]
Read moreIllumina Partners with D3b to Advance Genomic Research in Pediatric Rare Diseases
Rare Daily Staff Illumina and the Center for Data-Driven Discovery in Biomedicine (D3b) have entered a partnership […]
Read moreUC Berkeley Partners with BioMarin to Accelerate Rare Disease Research
The UC Berkeley Molecular Therapeutics Initiative (MTI) has entered into a new research collaboration with BioMarin Pharmaceutical […]
Read moreOxford-Harrington Awards Nearly $900K in Friedreich’s Ataxia Grants
Rare Daily Staff The Oxford-Harrington Rare Disease Centre’s FA Alliance Innovation Fund has awarded funding to five […]
Read moreMental Health & Wellness
RARE Advocacy Exchange Session 6 : Grieving a RARE Diagnosis
Rare disease grief differs from the grief we commonly associate with losing a loved one to death. […]
Read moreA Student’s Perspective: Lessons from the 2025 RARE Drug Development Symposium
During my first week as a Harvard College junior, I was delighted to be given the opportunity […]
Read moreGlobal Genes Guide to Securing a State Proclamation for Rare Disease Awareness
This Global Genes Quick Guide is a resource for advocates focused on pressing topics causing challenges in […]
Read moreGlobal Genes Guide to Your Rare Rights
This Global Genes Quick Guide is a resource for advocates focused on pressing topics causing challenges in […]
Read moreGlobal Genes Guide to Fundraising
This Global Genes Quick Guide is a resource for advocates focused on pressing topics causing challenges in […]
Read moreGlobal Genes Guide to Comprehensive Fundraising Strategic Documents
This Global Genes Quick Guide is a resource for advocates focused on pressing topics causing challenges in […]
Read moreRARE Advocacy Exchange Session 5 : Interacting with FDA: PFDD and Listening Sessions
If your rare disease is likely to have a clinical trial for a drug or treatment come […]
Read moreA PAG Leader Guide to Presenting the Patient Experience at Your EL-PFDD Session with the FDA.
A Global Genes Quick Guide is a resource for advocates focused on pressing topics causing challenges in […]
Read moreLove, Advocacy, and Belonging: Reflections from a Rare Disease Ally
By Nicole Boice, Chief Mission Officer, Global Genes As Chief Mission Officer at Global Genes—and as the […]
Read moreRARE Daily
Long Reads, Shorter Journeys
The ability to diagnose rare diseases is at a turning point as greater genomic awareness, technological advances […]
Read moreNovellia Raises $18 Million to Expand RWD Platform
Rare Daily Staff Novellia said it raised $18 million in a series A financing round to expand […]
Read moreBrainStorm Call for Updated FDA Approaches for Rare Disease Therapies in Journal Article
Rare Daily Staff BrainStorm Cell Therapeutics’ CEO has escalated the company’s long‑running dispute with the U.S. Food […]
Read moreRallybio Agrees to Reverse Merger
Rare Daily Staff Rare disease drug developer Rallybio said it agreed to a reverse merger with Avenzo […]
Read moreServier to Acquire Edgewise Muscular Dystrophy Business for up to $2.65 Billion
Servier to Acquire Edgewise Muscular Dystrophy Business for up to $2.65 Billion Rare Daily Staff Servier has […]
Read moreOak Hill Bio Raises $32.5 Million to Advance ASO in Angelman Syndrome
Rare Daily Staff Oak Hill Bio announced it has closed a $32.5 million series A financing to […]
Read moreSearch the RARE List
For more resources, disease-specific information, and news, search our RARE List- an extensive list of rare diseases and rare conditions.
Search Our Full RARE List